Peptide Nucleic Acids as a Tool for Site-Specific Gene Editing.

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• Peptide nucleic acids (PNAs) are DNA analogs capable of sequence-specific binding to duplex DNA.
• PNA-DNA triplex formation can modulate DNA repair pathways and induce targeted genome modifications.
• Early studies demonstrated PNA-mediated gene editing in cell-free systems.

Purpose of the Study:

• To review the advancements in PNA technology for gene editing applications.
• To highlight the therapeutic potential of PNAs in treating genetic disorders.
• To focus on recent in vivo and nanoparticle-based PNA strategies.

Main Methods:

• Review of literature on PNA-mediated gene editing.
• Analysis of studies demonstrating PNA applications in cell culture and preclinical models.
• Examination of nanoparticle-based delivery systems for in vivo PNA applications.

Main Results:

• PNAs have successfully corrected disease-causing mutations in human cells and preclinical mouse models.
• PNA-mediated gene correction has led to functional protein restoration and disease improvement.
• PNAs exhibit low off-target genome modification effects, suggesting a favorable safety profile.

Conclusions:

• PNAs represent a promising therapeutic strategy for the treatment and cure of genetic disorders.
• Continued development of PNA-based gene editing, particularly in vivo nanoparticle strategies, holds significant clinical potential.